Pravin Dugel, MD
Enriched profileExecutive Chairman, President, and Chief Executive Officer, Ocular Therapeutix, Inc. · Ocular Therapeutix
Pravin Dugel is Executive Chairman, President, and Chief Executive Officer, Ocular Therapeutix, Inc. at Ocular Therapeutix. ClinicalTrials.gov lists 7 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 2 Sept 2026
Pravin U. Dugel is Executive Chairman, President, and Chief Executive Officer, Ocular Therapeutix, Inc.. The public record shows 224 publications with 10,946 citations (h-index 58), centered on Macular Degeneration (AMD), Diabetic Retinopathy / DME. It also documents an investigator role on 7 registered clinical trials.
- Top research focus: Macular Degeneration (AMD)
- 7 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 2 Sept 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 2 Sept 2026
Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:
- Impact of Home Monitoring to Decrease the Treatment Burden for Neovascular Age-related Macular Degeneration (AMD)
Sponsor: Retinal Consultants of Arizona
- A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus
Sponsor: Retinal Consultants of Arizona
Industry payments
No payments involving this person were reported to CMS in program years 2021–2024. Why? →
Medicare prescribing footprint (2020)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
100%Vascular Endothelial Growth Factor Inhibitor86.9%Ranibizumab100%Part B, office-administered≥18 patientsCorticosteroid13.1%Prednisolone Acetate100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Online presence
Updated 2 Sept 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/pravin-dugel-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
ois.net/pravin-dugel
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ois.net ↗ - Other
asrs.org/annual-meeting/pravin-dugel-md-interview
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →asrs.org ↗ - Other
healio.com/authors/pdugel
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healio.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 2 Sept 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
David Geffen School of Medicine at UCLA
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ocutx.com ↗ - Undergraduate studies
Columbia University (graduated summa cum laude)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ocutx.com ↗ - Ophthalmology residency
USC Eye Institute, Keck School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ocutx.com ↗ - Medical retina fellowship
Bascom Palmer Eye Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ocutx.com ↗ - Surgical retina fellowship
USC Eye Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ocutx.com ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ocutx.com ↗
- Board of Directors
American Society of Retina Specialists (ASRS)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ocutx.com ↗ - Board Member
EURETINA
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ocutx.com ↗
Awards & honors
honors on the public record- Honor Award
American Academy of Ophthalmology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ocutx.com ↗ - Senior Honor Award
American Academy of Ophthalmology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ocutx.com ↗ - Lifetime Achievement Award
American Academy of Ophthalmology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ocutx.com ↗
Secondary affiliations
appointments beyond the home institution- Clinical Professor of Ophthalmology
Roski Eye Institute / USC Eye Institute, Keck School of Medicine, University of Southern California
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ocutx.com ↗ - Managing Partner
Retinal Consultants of Arizona and the Retinal Research Institute; Founding Member, Spectra Eye Institute (Sun City / Phoenix, AZ) -- listed as a prior leadership role on the Ocular Therapeutix bio …
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ocutx.com ↗
Media & interviews
press, podcasts and appearances- "The Retina TL;DR with Dr. Weng: Moving beyond anti-VEGF with OTX-TKI and Pravin U. Dugel, MD" -- Modern Retina podcast (2026)
hosted by Christina Y. Weng, MD, MBA …
2026verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →modernretina.com ↗ - Ocular Therapeutix CEO interview on retinal disease treatment challenges/opportunities
hosted by Joseph Coletti
2025provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →rbccm.com ↗ - "Success From Failure With Iveric Bio's Dr. Pravin Dugel" -- OIS Podcast episode #322 (April 20, 2022)
hosted by Firas Rahhal, MD, discussing NeoVista trial lessons and Zimura (avacincaptad pegol) for geographic atrophy
2022
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Ali Bijani
Babol University of Medical Sciences
Hamid Asayesh
Ayatollah Boroujerdi University
John J. Huang
Isfahan University of Medical Sciences
Fotis Topouzis
National University of Singapore